• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生殖系/编码变体与骨髓增殖性肿瘤风险增加相关。

Germline / Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms.

作者信息

Braunstein Evan M, Chen Hang, Juarez Felicia, Yang Fanghan, Tao Lindsay, Makhlin Igor, Williams Donna M, Chaturvedi Shruti, Pallavajjala Aparna, Karantanos Theodoros, Martin Renan, Wohler Elizabeth, Sobreira Nara, Gocke Christopher D, Moliterno Alison R

机构信息

Department of Medicine, Division of Haematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Department of Medicine, Division of Hematology & Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Cancers (Basel). 2021 Jun 29;13(13):3246. doi: 10.3390/cancers13133246.

DOI:10.3390/cancers13133246
PMID:34209587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8268839/
Abstract

Familial cases of myeloproliferative neoplasms (MPN) are relatively common, yet few inherited risk factors have been identified. Exome sequencing of a kindred with a familial cancer syndrome characterized by both MPN and melanoma produced a germline variant in the gene that co-segregates with disease. To further investigate whether germline variants contribute to MPN predisposition, the frequency of variants was analyzed in 1604 cases that underwent evaluation for hematologic malignancy, including 236 cases of MPN. MPN cases had a higher frequency of rare germline coding variants compared to non-MPN hematologic malignancies (8.9% vs. 4.1%, OR 2.4, 95% CI: 1.4 to 4.0, = 0.0028) as well as cases without a blood cancer diagnosis that served as an internal control (8.9% vs. 2.7%, OR 3.5, 95% CI: 1.4 to 8.3, = 0.0053). This finding was validated via comparison to an independent control cohort of 1587 cases without selection for hematologic malignancy (8.9% in MPN cases vs. 5.2% in controls, = 0.040). The most frequent variant identified, c.1960A > G; p.I654V, was present in MPN cases at more than twice its expected frequency. These data indicate that rare germline coding variants in are associated with an increased risk for development of MPN. The gene is a novel susceptibility locus which likely contributes to cancer risk in combination with additional risk alleles.

摘要

骨髓增殖性肿瘤(MPN)的家族性病例相对常见,但已确定的遗传风险因素较少。一个以MPN和黑色素瘤为特征的家族性癌症综合征家族的外显子组测序在与疾病共分离的基因中产生了一个种系变异。为了进一步研究种系变异是否导致MPN易感性,在1604例接受血液系统恶性肿瘤评估的病例中分析了变异的频率,其中包括236例MPN。与非MPN血液系统恶性肿瘤相比,MPN病例中罕见种系编码变异的频率更高(8.9%对4.1%,OR 2.4,95%CI:1.4至4.0,P = 0.0028),以及与作为内部对照的无血癌诊断的病例相比(8.9%对2.7%,OR 3.5,95%CI:1.4至8.3,P = 0.0053)。通过与1587例未选择血液系统恶性肿瘤的独立对照队列进行比较,验证了这一发现(MPN病例中为8.9%,对照中为5.2%,P = 0.040)。鉴定出的最常见变异c.1960A>G;p.I654V在MPN病例中的出现频率是预期频率的两倍多。这些数据表明,该基因中罕见的种系编码变异与MPN发生风险增加有关。该基因是一个新的易感位点,可能与其他风险等位基因共同导致癌症风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbb/8268839/1c2bb634257e/cancers-13-03246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbb/8268839/6f00ebd008d3/cancers-13-03246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbb/8268839/1c2bb634257e/cancers-13-03246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbb/8268839/6f00ebd008d3/cancers-13-03246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbb/8268839/1c2bb634257e/cancers-13-03246-g002.jpg

相似文献

1
Germline / Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms.生殖系/编码变体与骨髓增殖性肿瘤风险增加相关。
Cancers (Basel). 2021 Jun 29;13(13):3246. doi: 10.3390/cancers13133246.
2
Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes.导致骨髓增生性肿瘤和遗传性骨髓增生性表型的种系遗传变异。
Leuk Res. 2024 Nov;146:107566. doi: 10.1016/j.leukres.2024.107566. Epub 2024 Aug 25.
3
Functional Common and Rare Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility.功能常见和罕见种系变异在家族性和散发性癌症易感性中共同作用。
Cancer Prev Res (Phila). 2021 Apr;14(4):441-454. doi: 10.1158/1940-6207.CAPR-20-0094. Epub 2021 Jan 8.
4
Germline genetic factors in the pathogenesis of myeloproliferative neoplasms.胚系遗传因素在骨髓增殖性肿瘤发病机制中的作用。
Blood Rev. 2020 Jul;42:100710. doi: 10.1016/j.blre.2020.100710. Epub 2020 May 29.
5
Recurrent germline variant in ATM associated with familial myeloproliferative neoplasms.与家族性骨髓增生性肿瘤相关的 ATM 种系变异的重现。
Leukemia. 2023 Mar;37(3):627-635. doi: 10.1038/s41375-022-01797-6. Epub 2022 Dec 21.
6
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.家族性骨髓增殖性肿瘤发病机制的研究进展
Br J Haematol. 2017 Sep;178(5):689-698. doi: 10.1111/bjh.14713. Epub 2017 Apr 25.
7
Familial MPN Predisposition.家族性骨髓增殖性肿瘤易感性
Curr Hematol Malig Rep. 2017 Oct;12(5):442-447. doi: 10.1007/s11899-017-0414-x.
8
[Clinical Value of Genetic Susceptibility Genes for Myeloid Neoplasm in Myeloproliferative Neoplasm].[骨髓增殖性肿瘤中髓系肿瘤遗传易感性基因的临床价值]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023;31(4):1119-1124. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.029.
9
Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.骨髓增殖性肿瘤与实体瘤的同时出现归因于细胞减灭疗法与常见的端粒酶逆转录酶(TERT)基因多态性rs2736100之间的协同作用。
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):98-104. doi: 10.1158/1055-9965.EPI-15-0805. Epub 2015 Oct 20.
10
The Genetic Makeup of Myeloproliferative Neoplasms: Role of Germline Variants in Defining Disease Risk, Phenotypic Diversity and Outcome.骨髓增殖性肿瘤的遗传学特征:胚系变异在定义疾病风险、表型多样性和预后中的作用。
Cells. 2021 Sep 29;10(10):2597. doi: 10.3390/cells10102597.

引用本文的文献

1
Characterization of myeloproliferative neoplasms in the paediatric and young adult population.儿童和青年人群中的骨髓增殖性肿瘤特征。
Br J Haematol. 2023 May;201(3):449-458. doi: 10.1111/bjh.18650. Epub 2023 Jan 16.
2
Disruption of the HIF-1 pathway in individuals with Ollier disease and Maffucci syndrome.Ollier 病和 Maffucci 综合征患者中 HIF-1 通路的破坏。
PLoS Genet. 2022 Dec 8;18(12):e1010504. doi: 10.1371/journal.pgen.1010504. eCollection 2022 Dec.

本文引用的文献

1
Inherited causes of clonal haematopoiesis in 97,691 whole genomes.在 97691 个全基因组中发现的克隆性造血的遗传原因。
Nature. 2020 Oct;586(7831):763-768. doi: 10.1038/s41586-020-2819-2. Epub 2020 Oct 14.
2
Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells.遗传的骨髓增生性肿瘤风险影响造血干细胞。
Nature. 2020 Oct;586(7831):769-775. doi: 10.1038/s41586-020-2786-7. Epub 2020 Oct 14.
3
Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?骨髓增殖性肿瘤和多发性骨髓瘤是否具有相同的遗传易感性位点?
Int J Cancer. 2021 Apr 1;148(7):1616-1624. doi: 10.1002/ijc.33337. Epub 2020 Oct 27.
4
Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden.性别决定了骨髓增殖性肿瘤(MPN)的表现和预后,并且与突变负担中的性别特异性差异相关。
Blood Adv. 2020 Jun 23;4(12):2567-2576. doi: 10.1182/bloodadvances.2019001407.
5
Loss-of-function polymorphism in reduces risk of V617F somatic mutation and myeloproliferative neoplasm: A Mendelian randomization study.中的功能丧失多态性降低V617F体细胞突变和骨髓增殖性肿瘤的风险:一项孟德尔随机化研究。
EClinicalMedicine. 2020 Feb 19;21:100280. doi: 10.1016/j.eclinm.2020.100280. eCollection 2020 Apr.
6
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia.ERBB2/HER2突变在白血病中具有转化作用且可作为治疗靶点。
Leukemia. 2020 Oct;34(10):2798-2804. doi: 10.1038/s41375-020-0844-7. Epub 2020 May 4.
7
The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia.靶向基因panel 测序在鉴别血细胞减少病因中的诊断效用。
Am J Hematol. 2019 Oct;94(10):1141-1148. doi: 10.1002/ajh.25592. Epub 2019 Aug 7.
8
DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.髓系肿瘤中的 DDX41 突变与男性性别、TP53 突变和高危疾病相关。
Am J Hematol. 2019 Jul;94(7):757-766. doi: 10.1002/ajh.25486. Epub 2019 May 7.
9
The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.鉴定患者特异性突变揭示了大多数黑色素瘤患者存在双通路激活,而 BRAF/NRAS 野生型黑色素瘤中则存在激活的受体酪氨酸激酶。
Cancer. 2019 Feb 15;125(4):586-600. doi: 10.1002/cncr.31843. Epub 2018 Dec 18.
10
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations.可操作的激活致癌 ERBB2/HER2 跨膜和近膜结构域突变。
Cancer Cell. 2018 Nov 12;34(5):792-806.e5. doi: 10.1016/j.ccell.2018.09.010. Epub 2018 Oct 25.